NCT03206632View on ClinicalTrials.gov

This Study is Done in Healthy Chinese and Japanese Volunteers; it Looks at How BI 690517 is Taken up in the Body and How Well it is Tolerated

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

July 17, 2017

Primary Completion Date

October 13, 2017

Study Completion Date

October 13, 2017

Conditions
Healthy
Interventions
DRUG

BI 690517

single dose

DRUG

Placebo

single dose

Trial Locations (1)

03080

Seoul National University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT03206632 - This Study is Done in Healthy Chinese and Japanese Volunteers; it Looks at How BI 690517 is Taken up in the Body and How Well it is Tolerated | Biotech Hunter | Biotech Hunter